Channels - Recent advances in incretin biology and therapeutics: From glucose‐dependent insulinotropic polypeptide reappraisal to next‐generation agonists :: FRELIP Discovery

Similar Items: Recent advances in incretin biology and therapeutics: From glucose‐dependent insulinotropic polypeptide reappraisal to next‐generation agonists

Quick Look
Adaptive islet biology and comprehensive incretin physiology: Emerging perspectives from Asia and Europe
Quick Look
Real‐World vs. Randomized Trial Evidence for Incretin‐Based Therapies: A Narrative Review
Quick Look
c‐Jun N‐terminal kinase 3 as a permissive regulator of β‐cell incretin responsiveness
Quick Look
Five‐year follow‐up of incretin‐based therapy in a patient with KCNJ11‐related permanent neonatal diabetes: Achieving insulin discontinuation and sulfonylurea reduction
Quick Look
Glucagon-Like Peptide-1 Receptor Agonists: Their Potential Role in Prediabetes
Quick Look
Recent advances in pancreatic β‐cell dysfunction in type 2 diabetes mellitus: Intracellular stress and dedifferentiation
Quick Look
The association between the Triglyceride-Glucose index and skeletal muscle mass: insights from the Tehran Lipid and Glucose Study
Quick Look
Cost‐effectiveness analysis comparing real‐time continuous glucose monitoring with self‐monitoring of blood glucose for patients with type 2 diabetes treated with insulin in Japan
Quick Look
Factors associated with discrepancy between glycated hemoglobin and glucose management indicator
Quick Look
Cardiovascular outcomes of glucagon-like peptide-1 receptor agonists in patients without obesity: a systematic review and meta-analysis of randomized controlled trials
Quick Look
Blood Glucose Monitoring Expert Group and Best Practice Recommendation—FITTER BiG
Quick Look
Body mass index and peripheral neuropathy across the glucose tolerance spectrum in Japanese adults
Quick Look
Integrated Evidence from VigiBase and Clinical Trials: A Comprehensive Pharmacovigilance Analysis of Seven Glucagon-Like Peptide 1 Receptor Agonists (GLP-1 RAs)
Quick Look
Triglyceride-glucose index as a predictor of body composition changes in patients undergoing bariatric surgery
Quick Look
Application of competing risks models in cardiovascular mortality research: findings from the Tehran lipid and glucose study
Quick Look
Correction to “Association between continuous glucose monitoring metrics and diabetic retinopathy and albuminuria among Japanese individuals with type 1 diabetes”
Quick Look
Sodium–glucose cotransporter 2 inhibition and injection burden in mild diabetic macular edema: An exploratory post hoc analysis of the COMET trial
Quick Look
Impact of COVID‐19 restrictions and their relaxation on body composition and glycemic control in individuals with glucose intolerance in Japan: A single‐center observational study
Quick Look
Real-time continuous glucose monitoring in adults with type 2 diabetes managed with non-intensive insulin regimens: impact on glycemia and self-management
Quick Look
Effect of sodium–glucose cotransporter 2 inhibitors on heart failure readmission in older patients with diabetes: A Japanese claims‐based cohort study
Quick Look
Proteomic Evidence of Complement and Coagulation Pathway Dysregulation in Transfusion-Dependent Thalassemia
Quick Look
Mitochondrial Homeostasis in Pancreatic β Cell Function: Mechanisms and Therapeutic Targets for Diabetes
Quick Look
Quality of Life and Humanistic Burden of Adults with Type 1 Diabetes with Recurrent Severe Hypoglycemic Events and Impaired Awareness of Hypoglycemia Using a Continuous Glucose Monitor
Quick Look
A Prospective Multicenter Assessment of the Accuracy and Safety of the Yuwell CT3 Real‐Time Continuous Glucose Monitoring System in Patients With Diabetes Over 14 Days